Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Anemia, Sideroblastic
Pharmaceutical Research
Type VII Secretion Systems
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1801-8.
View in:
PubMed
subject areas
Aged
Carbazoles
Chi-Square Distribution
Comorbidity
Disease Progression
Double-Blind Method
Follow-Up Studies
Humans
Incidence
Longitudinal Studies
Middle Aged
Neoplasms
Parkinson Disease
authors with profiles
Christopher Goetz